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Introduction
The  initial  formation  of  many  major  structures  of  the 
human embryo takes place during a very narrow window 
of time in the first weeks after conception, often before a 
woman even knows she is pregnant. Any change in the 
early embryonic environment, including nutrient availa­
bility, has the potential to adversely or positively affect 
the developing embryo. Evidence is evolving that specific 
components of maternal diet can play a critical role in 
modifying the risk for birth defects.
The best example of the influence of maternal diet on 
birth defect risk is the intake of folic acid for prevention of 
neural  tube  defects  (NTDs)  [1].  Randomized  con  trolled 
folic acid intervention trials demonstrating the effective­
ness of folic acid for NTD risk reduction have led to the 
current public health recommendation, as well as folic acid 
fortification of the food supply [1]. Prevention of NTDs 
with supplemental folic acid is likely to involve a complex 
interaction between folic acid and multiple genetic factors; 
this is the focus of ongoing investigations [1].
The success of folic acid supplementation in reducing 
NTDs has led researchers to evaluate the association of 
other  dietary  components,  such  as  fat,  with  a  risk  for 
birth defects. Researchers have found that pre­pregnancy 
diabetes and obesity are associated with an increased risk 
for numerous birth defects (for example, specific heart 
defects,  NTDs  and  cleft  palate)  [2].  A  recent  meta­
analysis  revealed  that  certain  aspects  of  preconception 
care  reduced  the  risk  for  some  birth  defects  among 
women with diabetes: the risk reductions were associated 
with changes in behavior, such as increased folic acid use 
or improved glycemic control, or both (depending on the 
study) [2]. Both diabetes and obesity are related etiolo  gi­
cally to high­fat diets, although the mechanisms by which 
these conditions are or might be teratogenic during preg­
nancy  are  unclear.  A  high­fat  western  diet  has  been 
shown in a retrospective case­control study to be asso­
ciated with a more than twofold increased risk for cleft 
lip, with or without cleft palate [3]. The mechanisms by 
which dietary fat intake might influence the risk for birth 
defects remain under investigation.
High-fat diet and the risk for birth defects in mice
One of the strongest risk factors for many birth defects is 
a family history of the same defects; this reflects both 
genetic  and  environmental  risks  for  conditions  with 
complex inheritance patterns, and, as a result, it has been 
hypothesized that many birth defects have both genetic 
and  environmental  influences.  A  recent  paper  from 
Bentham et al. [4] described the interaction of a high­fat 
maternal  diet  and  the  embryonic  Cited2  genotype  in 
increasing  the  penetrance  of  left­right  patterning  birth 
defects  in  mouse  embryos.  The  phenotype  of  mice 
deficient in Cited2 varies both within and between mouse 
strains.  This  variable  penetrance  results  in  left­right 
patterning  defects  that  include  heart  defects  (septal, 
outflow  tract,  and  abnormal  ventricular  topology  with 
sinistral  looping)  and  right  atrial  and  pulmonary  iso­
merisms [5]. The evidence of increased penetrance (but 
not complete) in left­right patterning defects in certain 
mouse strains suggests a role for genetic modifiers of the 
phenotype, as well as a role for environmental influences. 
Bentham et al. also examined the possible role of the fat 
content of the maternal diet on the phenotype. They used 
a diet designed to mimic the high­fat, calorie­dense diet 
associated with the current obesity epidemic in the USA. 
It  contained  lard  in  place  of  starch,  which  has  been 
shown in previous studies to be associated with weight 
gain  and  fasting  hyperinsulinemia  [6].  The  experiment 
showed  that  the  high­fat  maternal  diet  increased  the 
penetrance  of  left­right  patterning  defects  in  mouse 
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© 2011 BioMed Central Ltdembryos  (60%  of  Cited2­/­  on  the  high­fat  diet  versus 
24%  of  Cited2­/­  on  the  control  diet).  The  severity  of 
cardiac  defects  was  greater  in  heterozygous  embryos 
(Cited2+/-)  from  the  high­fat  diet  group.  Additionally, 
embryos  on  the  high­fat  diet  exhibited  a  cleft  palate 
defect not reported previously for Cited2­/­. There were 
no defects in wild­type embryos on either diet. Further 
studies  revealed  that  there  were  greater  than  twofold 
decreases in Pitx2c expression in the embryos from the 
high­fat diet group with the Cited2­/­ genotype. Pitx2c 
deficiency is known to be associated with right atrial and 
pulmonary  isomerisms  [7].  A  high­fat  diet  increases 
adiposity  and  glucose  intolerance,  as  well  as  fasting 
hyperinsulinemia. However, it is unclear what aspect of 
the high­fat diet contributes to the increased penetrance 
and severity of the Cited2 genotype [6].
How do these results translate to humans?
The  role  of  Cited2  in  malformations  in  mice  is  clear; 
however,  among  humans,  there  have  been  limited 
numbers  of  studies  to  explore  the  effects  of  CITED2 
muta  tions. Sperling et al. [8] examined a group of 392 
human study participants with sporadic non­syndromic 
congenital  heart  disease,  and  seven  new  mutations  in 
CITED2 were found among eight of these participants. 
Additionally, a recent publication by Yang et al. [9] found 
three new mutations in CITED2 among 120 human study 
participants with congenital heart defects with a variety 
of  cardiac  lesions.  Consistent  with  the  variable  mouse 
phenotype, there were no clear groupings of the types of 
cardiac defects in the human studies associated with the 
CITED2 mutations, and even the same deletion resulted 
in different cardiac defects [8,9].
Mouse models can play a critical role in the discovery 
of  disease  pathology  because  they  allow  control  over 
variables that are uncontrollable among humans. However, 
results in mice can lead researchers astray, and results 
need  to  be  confirmed  carefully  through  use  of  human 
studies. For example, we know that folic acid food fortifi­
cation reduces NTD rates among human populations by 
19%  to  32%,  and  that  the  dietary  supplementation  of 
women of childbearing age with 400 µg folic acid per day 
reduces  NTD  rates  up  to  85%  among  humans  [1]. 
However, there are over 240 mouse models of NTDs, and 
only  a  minority  of  these  models  implicate  folic  acid 
metabolism through mutations in folate pathway genes 
or have been shown to be responsive to folic acid supple­
mentation [10]. So, it is unlikely that mouse models alone 
would  have  led  the  scientific  community  to  what  has 
become an effective public health intervention.
Future directions
The presence of CITED2 mutations in more than 2% of 
human study participants with congenital heart defects 
examined to date suggests that CITED2 might have a role 
in human malformations [8,9]. Interestingly, for some of 
the  same  types  of  defects  (for  example,  heart  defects, 
NTDs,  cleft  palate  and  heterotaxia)  seen  in  mice  with 
Cited2 mutations fed on a high­fat diet, associations with 
diabetes or obesity, or both, have been suggested in some 
human  studies  of  birth  defects  [6,7].  Significant  addi­
tional work is needed to determine if a similar interaction 
of  genotype  and  diet  is  applicable  to  human  embryo­
genesis. Larger population­based studies are needed to 
determine  the  effects  of  mutations  in  CITED2  on  the 
burden of specific types and constellations of malfor  ma­
tions  among  humans,  and  to  show  whether  these 
mutations have increased penetrance in the presence of 
high­fat maternal intake.
A  better  understanding  of  the  interface  of  gene­
environment  interactions  has  the  potential  to  increase 
our knowledge of the etiology of birth defects and lead to 
better targeted prevention programs. Interventions at the 
maternal­fetal  interface  are  complex  because  of  the 
environmental  interaction  with  both  the  maternal  and 
fetal genomes during critically limited windows of time. 
Before any changes in dietary recommendations can be 
made, additional large­scale studies are needed to define 
the  ‘at­risk’  population,  followed  by  randomized  con­
trolled trials to determine whether changes in diet can 
modify the risk and reduce the burden of birth defects.
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